Clinigen Group, Plc. Release: Board Appointment

Clinigen Group plc (AIM: CLIN, "Clinigen" or the "Group"), the global specialty pharmaceuticals business, announces that upon completion earlier today of the acquisition of Link Healthcare Private Limited ("Link") (the "Acquisition") (see separate announcement), John Bacon joined the Group as a Non-Executive Director. Johannes Willemse will act as John Bacon’s alternate on the Clinigen board (the “Board”).

Mr Bacon founded Link in 1997 thereby pioneering the supply of specialist pharmaceuticals in the Australian market. He served as Executive Chairman of Link before its acquisition by Clinigen. Prior to forming Link, John held senior positions in the pharmaceutical industry across the Asia-Pacific region.

Mr Willemse has over 25 years of experience in the pharmaceutical industry. He served as Chief Executive Officer of Link prior to its acquisition by Clinigen.

Mr Bacon holds 930,767 ordinary shares of 0.1p each in Clinigen. Mr Willemse does not hold any shares in Clinigen. However, Mr Willemse is beneficially interested in Vector Pharma Holdings Private Limited which itself holds 2,113,835 ordinary shares of 0.1p each in Clinigen. Both Mr Bacon and Vector Pharma Holdings Private Limited received their holdings in Clinigen today as part consideration for their interests in Link.

Peter Allen, Chairman, Clinigen, said: “On behalf of the Board, I welcome John to the team and I am pleased that Johannes has agreed to act as his alternate. Our strategic acquisition of Link has strengthened both Clinigen’s international distribution network across the AAA region - Asia, Africa and Australasia - as well as our management team. Together, we can better meet the growing demand for much needed, but not always licensed, medicines across the world.”

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies. John Middleton Bacon, aged 57, has been a director of the following companies during the five years preceding the date of this announcement:

Current directorship
Anggatha Pty ltd
Ingenia Developments Pty Ltd
The Medical Stockings Company
JM & LJ Investments Pty Ltd
JM & LJ Superannuation Management Pty Ltd
Ingeneia Pty Ltd

Past directorship
Link Healthcare Private Limited
Link Healthcare Singapore Pte Ltd
Link Healthcare Pty Ltd
Link Holding 1 Pty Ltd
Link Holding 2 Pty Ltd
Link Medical Products Pty Ltd
Link Pharmaceuticals Ltd
Medical Stockings Pty Ltd
Debra Australia Limited
Split It PTY LTD
Whey To Go Pty Ltd
Flordis Herbal Medicines
Royal Prince Alfred Yacht Club

Johannes Willemse, aged 47, currently holds director positions in the following companies:

Link Healthcare Private Limited
Link Healthcare Hong Kong Ltd
Link Healthcare Singapore Pte Ltd
Link Healthcare KK
Link Pharmaceutical KK
Link Healthcare Pty Ltd
Link Medical Products Pty Ltd
Link Healthcare SDN. BHD.
Link Healthcare Pty Ltd (trading as Equity Pharma Holdings)
Homemed Pty Ltd
Equity Pharmaceuticals Pty Ltd
Equity Medical Technologies Pty Ltd
Equipharm Specialized Distribution Pty Ltd
Novagen Pharma Pty Ltd
Plurilinx (Pty) Ltd
Chloromix (Pty) Ltd

Mr Willemse was also, within the last five years, a director of Equity Dental (Pty) Limited.

There is no further information to be disclosed pursuant to Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

Help employers find you! Check out all the jobs and post your resume.